Dentium CO., LTD (KRX:145720)
64,500
-500 (-0.77%)
At close: Jul 31, 2025, 3:30 PM KST
Heartland Financial USA Market Cap
Dentium CO., LTD has a market cap or net worth of 534.68 billion as of August 1, 2025. Its market cap has decreased by -43.79% in one year.
Market Cap
534.68B
Enterprise Value
688.19B
Revenue
401.91B
Ranking
n/a
PE Ratio
7.79
Stock Price
$64,500.00
Market Cap Chart
Since March 15, 2017, Dentium CO., LTD's market cap has increased from 295.94B to 534.68B, an increase of 80.67%. That is a compound annual growth rate of 7.31%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 534.68B | -0.32% |
Dec 30, 2024 | 536.41B | -52.52% |
Dec 28, 2023 | 1,129.73B | 31.00% |
Dec 29, 2022 | 862.39B | 43.27% |
Dec 30, 2021 | 601.95B | 69.83% |
Dec 30, 2020 | 354.44B | -23.61% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Mar 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.59T |
Celltrion | 37.76T |
ALTEOGEN | 22.55T |
Yuhan | 8,432.74B |
SK Biopharmaceuticals | 7,345.78B |
Peptron | 6,523.26B |
HLB Co., Ltd. | 6,040.81B |
PharmaResearch | 5,724.70B |